# Engene Therapeutics Inc enGene Therapeutics, Inc.

Engene Therapeutics Inc enGene Therapeutics, Inc. is a security (CUSIP 29286X119) tracked across SEC portfolio filings. 1 registered fund positions totaling n/a via N-PORT as of 2026-04-30.

## Summary

- Issuer: Engene Therapeutics Inc
- Class: enGene Therapeutics, Inc.
- CUSIP: 29286X119
- Asset category: DE
- 13F holders: 0
- N-PORT fund positions: 1
- N-PORT report: 2026-04-30

## Top fund holders (N-PORT)

| Fund | Registrant | Value | % of fund |
| --- | --- | --- | --- |
| Saba Capital Income & Opportunities Fund | Saba Capital Income & Opportunities Fund | — | 0.00% |

## More

- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/security/29286X119.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.